Mechanisms of neisserial serum resistance

Molecular Microbiology

Volumn 32, Issue 6, 1999, Pages 1133-1139

  Vogel, Ulrich ^a   Frosch, Matthias ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; COMPLEMENT; POLYSACCHARIDE; PORIN;

BACTERIAL IMMUNITY; BACTERIAL OUTER MEMBRANE; BACTERIAL VIRULENCE; COMPLEMENT ACTIVATION; EPIDEMIC MENINGITIS; GENETIC DISORDER; GONORRHEA; HUMAN; INFLAMMATION; MENINGOCOCCOSIS; NEISSERIA; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SERUM BACTERICIDAL ACTIVITY;

ANIMALS; COMPLEMENT SYSTEM PROTEINS; HUMANS; LIPOPOLYSACCHARIDES; NEISSERIA GONORRHOEAE; NEISSERIA MENINGITIDIS; POLYSACCHARIDES; PORINS;

EID: 0033062972     PISSN: 0950382X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2958.1999.01469.x     Document Type: Review

References (46)

1. Andoh, A., Fujiyama, Y., Kimura, T., Uchihara, H., Sakumoto, H., Okabe, H., et al. (1997) Molecular characterization of complement components (C3, C4 and factor B) in human saliva. J Clin Immunol 17: 404-407
2. Brandtzaeg, P. (1995) Pathogenesis of meningococcal infections. In Meningococcal Disease. Cartwright, K. (ed.). Chichester: John Wiley and Sons, pp. 71-114
3. Brandtzaeg, P., Mollnes, T.E., and Kierulf, P. (1989) Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis 160: 58-65
4. Carbonetti, N., Simnad, V., Elkins, C., and Sparling, P.F. (1990) Construction of isogenic gonococci with variable porin structure: effects on susceptibility to human serum and antibiotics. Mol Microbiol 4: 1009-1018
5. + Neisseria gonorrhoeae from the bactericidal action of normal human serum. Infect Immun 63: 1790-1795
6. DiScipio, R.G. (1997) Late components. In The Complement System. Rother, K., Till, G.O., and Hänsch, G.M. (eds). Berlin: Springer, pp. 50-68
7. Erwin, A.L., Haynes, P.A., Rice, P.A., and Gotschlich, E.C. (1996) Conservation of the lipooligosaccharide synthesis locus Igt among strains of Neisseria gonorrhoeae: requirement for IgtE in synthesis of the 2C7 epitope and of the beta chain of strain 15253. J Exp Med 184: 1233-1241
8. Estabrook, M.M., Griffiss, J.M., and Jarvis, G.A. (1997) Sialylation of Neisseria meningitidis lipooligosaccharide inhibits serum bactericidal activity by masking lacto-N-neotetraose. Infect Immun 65: 4436-4444
9. Figueroa, J.E., and Densen, P. (1991) Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 4: 359-395
10. Fijen, C.A.P., Kuijper, E.J., Dankert, J., Daha, M.R., and Caugant, D.A. (1998) Characterization of Neisseria meningitidis strains causing disease in complement-deficient and complement-sufficient patients. J Clin Microbiol 36: 2342-2345
11. Gilbert, M., Watson, D.C., Cunningham, A.M., Jennings, M.P., Young, N.M., and Wakarchuk, W.W. (1996) Cloning of the lipooligosaccharide alpha-2,3-sialyltransferase from the bacterial pathogens Neisseria meningitidis and Neisseria gonorrhoeae. J Biol Chem 271: 28271-28276
12. Hamadeh, R.M., Estabrook, M.M., Zhou, P., Jarvis, G.A., and Griffiss, J.M. (1995) Anti-Gal binds to pili of Neisseria meningitidis: the immunoglobulin A isotype blocks complement-mediated killing. Infect Immun 63: 4900-4906
13. Hazelzet, J.A., van der Voort, E., Lindemans, J., ter Heerdt, P.G.J., and Neijens, H.J. (1994) Relation between cytokines and routine laboratory data in children with septic shock and purpura. Intens Care Med 20: 371-374
14. Hazelzet, J.A., de Groot, R., van Mierlo, G., Joosten, K.F.M., van der Voort, E., Eerenberg, A., et al. (1998) Complement activation in relation to capillary leakage in children with septic shock and purpura. Infect Immun 66: 5350-5356
15. Hitchcock, P.J. (1984) Analysis of gonococcal lipopolysaccharide in whole-cell lysates by sodium dodecyl sulfate-polyacrylamide gel electrophoresis: stable association of lipopolysaccharide with the major outer membrane protein (protein I) of Neisseria gonorrhoeae. Infect Immun 46: 202-212
16. Jack, D.L., Dodds, A.W., Anwar, N., Ison, C.A., Law, A., Frosch, M., et al. (1998) Activation of complement by mannose-binding lectin on isogenic mutants of Neisseria meningitidis serogroup B. J Immunol 160: 1346-1353
17. Jennings, M.P., Hood, D.W., Peak, I.R., Virji, M., and Moxon, E.R. (1995) Molecular analysis of a locus for the biosynthesis and phase-variable expression of the lacto-N-neotetraose terminal lipopolysaccharide structure in Neisseria meningitidis. Mol Microbiol 18: 729-740
18. Jones, D.M., Borrow, R., Fox, A.J., Gray, S., Cartwright, K.A., and Poolman, J.T. (1992) The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis. Microb Pathog 13: 219-224
19. Judd, R.C. (1989) Protein I: structure, function, and genetics. Clin Microbiol Rev 2 (Suppl.): S41-S48
20. Kahler, C.M., Martin, L.E., Shih, G.C., Rahman, M.M., Carlson, R.W., and Stephens, D.S. (1998) The (alpha 2→8)-linked polysialic acid capsule and lipooligosaccharide structure both contribute to the ability of serogroup B Neisseria meningitidis to resist the bactericidal activity of normal human serum. Infect Immun 66: 5939-5947
21. Lee, F.K., Stephens, D.S., Gibson, B.W., Engstrom, J.J., Zhou, D., and Apicella, M.A. (1995) Microheterogeneity of Neisseria lipooligosaccharide: analysis of a UDP-glucose 4-epimerase mutant of Neisseria meningitidis NMB. Infect Immun 63: 2508-2515
22. Mackinnon, F.G., Borrow, R., Gorringe, A.R., Fox, A.J., Jones, D.M., and Robinson, A. (1993) Demonstration of lipooligosaccharide immunotype and capsule as virulence factors for Neisseria meningitidis using an infant mouse intranasal infection model. Microb Pathog 15: 359-366
23. McQuillen, D.P., Gulati, S., Ram, S., Turner, A.K., Jani, D.B., Heeren, T.C., et al. (1999) Complement processing and immunoglobulin binding to Neisseria gonorrhoeae determined in vitro simulates in vivo effects. J Infect Dis 179: 124-135
24. Mandrell, R.E., and Apicella, M.A. (1993) Lipo-oligosaccharides (LOS) of mucosal pathogens: molecular mimicry and host-modification of LOS. Immunobiology 187: 382-402
25. Mandrell, R.E., Kim, J.J., John, C.M., Gibson, B.W., Sugai, J.V., Apicella, M.A., et al. (1991) Endogenous sialylation of the lipooligosaccharides of Neisseria meningitidis. J Bacteriol 173: 2823-2832
26. Meri, S., and Pangburn, M.K. (1990) Discrimination between activators and nonactivators of the alternative pathway of complement: regulation via a sialic acid/polyanion binding site on factor H. Proc Natl Acad Sci USA 87: 3982-3986
27. Morello, J.A., and Bohnhoff, M. (1989) Serovars and serum resistance of Neisseria gonorrhoeae from disseminated and uncomplicated infections. J Infect Dis 160: 1012-1017
28. Nairn, C.A., Cole, J.A., Patel, P.V., Parsons, N.J., Fox, J.E., and Smith, H. (1988) Cytidine 5′-monophospho-N-acetyl-neuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum. J Gen Microbiol 134: 3295-3306
29. Nilsson, B., and Nilsson Ekdahl, K. (1997) Components of the alternative pathway. In The Complement System, Rother, K., Till, G.O., and Hänsch, G.M. (eds). Berlin: Springer, pp. 23-49
30. Pangburn, M.K. (1997) Alternative pathway: activation and regulation. In The Complement System. Rother, K., Till, G.O., and Hänsch, G.M. (eds). Berlin: Springer, pp. 93-115
31. Parsons, N.J., Andrade, J.R., Patel, P.V., Cole, J.A., and Smith, H. (1989) Sialylation of lipopolysaccharide and loss of absorption of bactericidal antibody during conversion of gonococci to serum resistance by cytidine 5′-monophospho-N-acetyl neuraminic acid. Microb Pathog 7: 63-72
32. Pettersson, A., Maas, A., van Wassenaar, D., van der Ley, P., and Tommassen, J. (1995) Molecular characterization of FrpB, the 70-kilodalton iron-regulated outer membrane protein of Neisseria meningitidis. Infect Immun 63: 4181-4184
33. Pilatte, Y., Bignon, J., and Lambre, C.R. (1993) Sialic acids as important molecules in the regulation of the immune system: pathophysiological implications of sialidases in immunity. Glycobiology 3: 201-218
34. Ram, S., McQuillen, D.P., Gulati, S., Elkins, C., Pangburn, M.K., and Rice, P.A. (1998a) Binding of complement factor H to loop 5 of porin protein 1A: a molecular mechanism of serum resistance of nonsialylated Neisseria gonorrhoeae. J Exp Med 188: 671-680
35. Ram, S., Sharma, A.K., Simpson, S.D., Gulati, S., McQuillen, D.P., Pangburn, M.K., and Rice, P.A. (1998b) A novel sialic acid binding site on factor H mediates serum resistance of sialylated Neisseria gonorrhoeae. J Exp Med 187: 743-752
36. Reid, K.B.M. (1997a) Classical pathway of activation. In The Complement System. Rother, K., Till, G.O., and Hänsch, G.M. (eds). Berlin: Springer, pp. 68-86
37. Reid, K.B.M. (1997b) Lectin-pathway of non-self recognition. In The Complement System. Rother, K., Till, G.O., and Hänsch, G.M. (eds). Berlin: Springer, pp. 86-92
38. Robertson, B.D., Frosch, M., and van Putten, J.P. (1993) The role of galE in the biosynthesis and function of gonococcal lipopolysaccharide. Mol Microbiol 8: 891-901
39. Summerfield, J.A., Ryder, S., Sumiya, M., Thursz, M., Gorchein, A., Monteil, M.A., et al. (1995) Mannose binding protein gene mutations associated with unusual and severe infections in adults. Lancet 345: 886-889
40. Vogel, U., Hammerschmidt, S., and Frosch, M. (1996) Sialic acids of both the capsule and the sialylated lipooligosaccharide of Neisseria meningitidis serogroup B are prerequisites for virulence of meningococci in the infant rat. Med Microbiol Immunol Berlin 185: 81-87
41. Vogel, U., Weinberger, A., Frank, R., Muller, A., Kohl, J., Atkinson, J.P., et al. (1997a) Complement factor C3 deposition and serum resistance in isogenic capsule and LOS sialic acid mutants of serogroup B Neisseria meningitidis. Infect Immun 65: 4022-4029
42. Vogel, U., Claus, H., Heinze, G., and Frosch, M. (1997b) Functional characterization of an isogenic meningococcal α-2,3-sialyltransferase mutant: the role of lipooligosaccharide for serum resistance in serogroup B meningococci. Med Microbiol Immunol Berlin 186: 159-166
43. Vogel, U., Claus, H., Heinze, G., and Frosch, M. (1999) Role of lipopolysaccharide sialylation in serum resistance of serogroup B and C meningococcal disease isolates. Infect Immun 76: 954-957
44. Waring, P.M., Presneill, J., Maher, D.W., Layton, J.E., Cebon, J., Waring, L.J., et al. (1995) Differential alterations in plasma colony-stimulating factor concentrations in meningococcemia. Clin Exp Immunol 102: 501-506
45. Weiser, J.N., Goldberg, J.B., Pan, N., Wilson, L., and Virji, M. (1998) The phosphorylcholine epitope undergoes phase variation on a 43-kilodalton protein in Pseudomonas aeruginosa and on pili of Neisseria meningitidis and Neisseria gonorrhoeae. Infect Immun 66: 4263-4267
46. Wright, S.D., and Levine, R.P. (1981) How complement kills E. coli. I. Location of the lethal lesion. J Immunol 127: 1146-1151